Supply Of Kanakinumab Drug, Subcutaneous Injection Solution, 150 Mg/Ml In Implementation Of Government Decision No. 545 Of 6 April 2021 On The Procedure For The Acquisition Of Medicines, Medical Products And Technical Rehabilitation For A Particular Child With A Severe Life-Threatening And Chronic Disease, Including A Rare (Orphan) Disease, Or For Groups Of Such Children

oЕДЕРАЛЬНОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ oЕДЕРАЛЬНЫЙ ЦЕНТР ПЛАНИРОВАНИЯ И ОРГАНИЗАЦИИ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ГРАЖДАН МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ oЕДЕРАЦИИ Russia has Released a tender for Supply Of Kanakinumab Drug, Subcutaneous Injection Solution, 150 Mg/Ml In Implementation Of Government Decision No. 545 Of 6 April 2021 On The Procedure For The Acquisition Of Medicines, Medical Products And Technical Rehabilitation For A Particular Child With A Severe Life-Threatening And Chronic Disease, Including A Rare (Orphan) Disease, Or For Groups Of Such Children in Pharmaceuticals. The tender was released on Jul 04, 2024.

Country - Russia

Summary - Supply Of Kanakinumab Drug, Subcutaneous Injection Solution, 150 Mg/Ml In Implementation Of Government Decision No. 545 Of 6 April 2021 On The Procedure For The Acquisition Of Medicines, Medical Products And Technical Rehabilitation For A Particular Child With A Severe Life-Threatening And Chronic Disease, Including A Rare (Orphan) Disease, Or For Groups Of Such Children

Deadline - login to view

GT reference number - 83641188

Product classification - Medicinal products for the alimentary tract and metabolism